CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹1,213 Cr | ₹864 Cr | ₹689 Cr | ₹383 Cr | ₹571 Cr |
What is the latest Capital Work in Progress ratio of CIPLA ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹1,213 Cr |
| Mar2024 | ₹864 Cr |
| Mar2023 | ₹689 Cr |
| Mar2022 | ₹383 Cr |
| Mar2021 | ₹571 Cr |
How is Capital Work in Progress of CIPLA Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,213 Cr | 40.31 | |
| Mar2024 | ₹864 Cr | 25.41 | |
| Mar2023 | ₹689 Cr | 79.99 | |
| Mar2022 | ₹383 Cr | -32.92 | |
| Mar2021 | ₹571 Cr | - | |
Compare Capital Work in Progress of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹120,717.6 Cr | -1.2% | -2% | 2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,086.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,616.0 Cr | -1.9% | -1.6% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,361.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,881.0 Cr | -1.2% | 1.5% | -6.1% | Stock Analytics | |
| MANKIND PHARMA | ₹90,069.9 Cr | -0.3% | -3% | -24.7% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -1.2% |
-2% |
2% |
| SENSEX | -0.3% |
-1.1% |
7.8% |
You may also like the below Video Courses